ARIUS Research licenses Biotracker™ from Ocimum Biosolutions
Ocimum Biosolutions, a leading provider of a Laboratory Information Management System (LIMS) and Bioinformatics solutions, announced that ARIUS Research Inc. of Toronto, Ontario (TSX-V:ARI)has licensed their Biotracker™ LIMS solution to enhance their State-of-the-art Cancer Research facilities in downtown Toronto. The implementation partner for Ocimum is UBI, United Bioinformatica Inc, Canada.
ARIUS Research is focused on discovering and developing novel cancer therapies through their FunctionFIRST™ platform. In order to support corporate growth ARIUS has taken the step on implementing a LIMS to manage the volume and complexity of data generated during drug development. Biotracker™ LIMS was selected for its flexibility, feature rich components, and ability to integrate numerous complex data systems. The combination of the Biotracker LIMS and Ocimum customer service was determined to best meet the company’s needs.
Ms Anuradha Acharya, CEO, Ocimum Biosolutions said, “We at Ocimum realize problems faced by a typical research lab in combining different software tools and also different data types. We expect that Biotracker™ will be vastly beneficial to ARIUS Research in integrating, maintaining and enhancing data management.”
About ARIUS Research
ARIUS Research Inc. is a biotechnology company dedicated to personalizing cancer therapy through the discovery and development of novel anticancer monoclonal antibodies (MAbs). Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST™ that rapidly identifies powerful MAbs targeting a variety of cancer indications. This antibody generation engine has enabled ARIUS to assemble a growing pipeline of over 200 functional MAbs, which may be used for commercial collaborations, out-licensing or in-house development. ARIUS has ongoing licensing and research partnerships with key biotechnology and drug development companies that provide revenues and access to external technologies. The long-term vision of ARIUS is to deliver personalized therapy by matching multiple antibodies to the distinct antigenic characteristics of each patient’s tumour cells thereby increasing efficacy and avoiding side effects.
About Biotracker™
Biotracker™ is a multi-platform GLP compliant Laboratory Information Management System. The software enables life sciences labs to keep an accurate track of samples, reagents, instruments, processes and output from the time these samples or resources are acquired, right through to the final stage of research. Biotracker™comes with a multi-level user configurable security feature. Biotracker™ also provides easy and low-cost instrument and application interfacing. This software is a comprehensive lab information and knowledge management system compliant with GLP and based on guidelines set forth by US FDA 21 CFR Part 11.
About Ocimum Biosolutions
Ocimum Biosolutions is an ISO 9001:2000 certified life sciences contract R&D Company that provides cost-effective customized contract research services and next generation bioinformatics tools & services in the area of genomics, proteomics and laboratory information management (LIMS) for Biotech and Pharmaceutical industry. The company’s other products include: (1) Sequence Analysis package – Genchek™ (2) Microarray data analysis suite- Genowiz™ (3) Gene Optimization tool – OptGene™ (4) siRNA design – iRNAwiz™ and (5) LIMS for pre-clinical research – Toxchek™ . Ocimum plans to launch a LIMS – Pharmatracker™ targeted towards the Pharmaceutical industry by the end of the year.
Ocimum Biosolutions is a Delaware registered company with its operations at Indianapolis and sales and distribution channels across the world. Ocimum’s Indian arm is located at Hyderabad. For more information on Ocimum Biosolutions visit www.ocimumbio.com or contact bdm@ocimumbio.com .
